1.A Preliminary Study on the Differentiation of Bone-marrow Mesenchymal Stem Cells into Neuron-like Cells in Vitro after Transfected by Brain-derived Neurotrophic Factor Gene
Qianxu LIU ; Dinghua XIE ; Guangui CHEN
Journal of Audiology and Speech Pathology 1998;0(03):-
Objective To investigate the function of bone-marrow mesenchymal stem cells(BMSCs) differentiating into neuron-like cells in vitro after transfected by human brain-derived neurotrophic factor (BDNF) gene.Methods Human BDNF genes were cloned and recombinant pcDNA3.1(-)-BDNF plasmids were constructed. BMSCs from five guinea pigs were isolated and cultured while their morphologies were observed by microscope. The surface antigen was detected by flowcytometry. BDNF genes were transfected into BMSCs with electroporation,and the transfected BMSCs were induced by ratinoic acid(RA)after bolted by Geneticin-418(G418),then the differentiated BMSCs were identified by immunocytochemistry. Results The culture cells demonstroted the typical morphology and surface antigen of BMSCs. The transfected cells expressed neuron-specific enolase(NSE),Nestin and glial fibrillary acid protein(GFAP) also secreted BDNF.Conclusion BMSCs transfected by BDNF genes can differentiate into neuron-like cells in vitro,electroporation can enhame the transfection efficiency,RA can promote cell induction.
2.A Preliminary Study on the Differentiation of bone-marrow mesenchymal Stem Cells into Neuron-like Cells in Vitro after transfected by Brain- derived neurotrophic Factor Gene
Qianxu LIU ; Dinghua XIE ; Guangui CHEN
Journal of Audiology and Speech Pathology 2009;17(3):252-255
Objective To investigate the function of bone-marrow mesenehymal stem eells(BMSCs) differ-entiating into neuron-like cells in vitro after transfected by human brain-derived neurotrophie factor (BDNF) gene. Methods Human BDNF genes were cloned and recombinant pcDNA3. 1(-)-BDNF plasmids were construc-ted. BMSCs from five guinea pigs were isolated and cultured while their morphologies were observed by microscope. The surface antigen was detected by flowcytometry. BDNF genes were transfected into BMSCs with electroporation, and the transfected BMSCs were induced by ratinoie acid(RA)after bolted by Geneticin-418 (G418), then the dif-ferentiated BMSCs were identified by immunocytochemistry. Results The culture ceils demonstroted the typical mor-phology and surface antigen of BMSCs. The transfected cells expressed neuron- specific enolase(NSE), Nestin and glial fi-brillary acid protein(GFAP) also secreted BDNF. Conclusion BMSCs transfected by BDNF genes can differentiate into neu-ron- like cells in vitro, electroporation can enhame the transfection efficiency, RA can promote cell induction.
3.Non-virus vector methods in hBDNF gene transfected bone marrow mesenchymal stem cells :Lipofectamine versus electroporation
Guangui CHEN ; Qianxu LIU ; Dinghua XIE
Chinese Journal of Tissue Engineering Research 2010;14(10):1847-1852
BACKGROUND:Gene transfection of cells includes virus and non-virus vector.As virus vector has some issues,such as safety and immunological rejection,the present study explored lipofectamine and electroporation transfection methods.OBJECTIVE:To establish genetic engineering cells using human brain-derived neurotrophic factor(hBDNF)gene transfected bone marrow mesenchymal stem cells(BMMSCs)by lipofectamine or electroporation,and explore its characteristics and expression in vitro.METHODS:Lipofectamine method:The BMMSCs were obtained from the tibias and femurs of the guinea pigs.The third passage BMMSCs were cultured with plasmid-lipofectamine mixture for 6 hours,followed by fetal bovine medium for 48 hours.Immunohistochemistry was performed for transient expression.G418 was added after 48 hours.Electroporation method:BMMSCs were trypsinized and resuspended with serum-free medium.Cell suspension was added into electrotransformation pool,and plasmid was added.The electrotransformation pool was moved between electrodes.After transfection for 48 hours,gene transient expression was detected.G418 was added after 48 hours.Brain-derived neurotrophic factor expression was detected by immunohistochemistry and RT-PCR.RESULTS AND CONCLUSION:Immunohistochemistry showed that BDNF transient expression was 5.80% by lipofectamine and 24.29% by electroporation.Cells almost died at 14 days following lipofectamine transfection.Stable expression cell lines of BDNF engineered BMMSC were successfully established by electroporation,with 90% expressive rate by immunohistochemistry and expression of BDNF mRNA by RT-PCR.Genetic engineering cells using BDNF transected BMMSC were established by electroporation whereas failed by lipofectamine,and the expressed BDNF was confirmed by immunohistochemistry and RT-PCR in vitro.
4.Effect of Amikacin on Aquaporin 4 Expression in Mice Inner Ear
Guangui CHEN ; Yali XU ; Min MAO ; Lizi QIU
Journal of Audiology and Speech Pathology 2013;(6):600-602,603
Objective To study the effect of amikacin on aquaporin 4 (AQP4) expression in mice inner ear and reveal the possible mechanism of amikacin ototoxicity .Methods A total of 60 CBA/CaJ mice were randomly di-vided into experimental group and control group with 30 mice in each group .Experimental group mice were subcuta-neously injected with 450 mg/kg amikacin once a day for 2 weeks ,meanwhile control group mice were injected with normal saline .The expression of AQP4 were detected by immunohistochemistry .The changes of AQP4 protein and mRNA abundance were detected separately by Westen Blots and RT -PCR .Results AQP4 in mice inner ear mainly located in supported cells in Corti’s organ .AQP4 protein abundance in experimental group and control group were 0 .672 ± 0 .074 and 0 .479 ± 0 .108 ,mRNA abundance were 0 .701 ± 0 .107 and 0 .460 ± 0 .080 ,respectively .The a-bundance of AQP4 protein and mRNA in inner ear in amikacin -treated mice were significantly lower than those of in control group .Conclusion Amikacin may down -regulate AQP4 expression in mice inner ear .
5.Effect of ossicular chain reconstruction with titanium ossicular replacement prosthesis in mastoidectomy with synchronous ossiculoplasty.
Min MAO ; Jinming ZHAI ; Guangui CHEN ; Jianguo ZHANG ; Zhaoen MA ; Jinping XUE
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2014;28(10):708-711
OBJECTIVE:
To assess hearing effect of ossicular chain reconstruction with titanium ossicular replacement prosthesis during mastoidectomy with synchronous ossiculoplasty in chronic middle ear disease.
METHOD:
Retrospective reviews were performed for 139 patients who had underwent mastoidectomy and tympanoplasty with titanium ossicular replacement prostheses at the same time between 2008 and 2011. The partial ossicular replacement prostheses (PORP) were used in 91 patients and the total ossicular replacement prostheses (TORP) were used in 48 patients respectively. All patients had follow-up for 2 to 5 years. The preoperative and postoperative mean air conduction and air-bone gaps(ABG) for the four frequencies (0.5, 1.0, 2.0 and 4.0 kHz) were evaluated. The improvement of mean air conduction and ABG over the same frequencies were measured. A postoperative ABG less than or equal to 20 dB was considered a successful operation. The hearing results of titanium PORP and TORP were compared.
RESULT:
The mean air conductions were (53.97 +/- 11.32)dB and (36.80 +/- 11.68) dB preoperatively and postoperatively in PORP group. The mean improvement in air conduction was (17.17 +/- 5.79)dB. The mean ABG was (31.84 +/- 6.17)dB and (15.13 +/- 7.22)dB preoperatively and postoperatively in PORP group. The mean improvement in ABG was (17.71 +/- 5.5)dB. The difference of hearing threshold between preoperative and postoperative had statistical significance (P < 0.01). The mean air conduction were (58.05 +/- 11.35)dB and (44.53 +/- 13.15)dB preoperatively and postoperatively in TORP group. The mean improvement in air conduction was (13.52 +/- 7.81)dB. The mean ABG; were (35.67 +/- 5.73)dB and (21.48 +/- 7.01)dB preoperatively and postoperatively for TORP group. The mean improvement of hearing threshold in ABG was (14.18 +/- 7.53)dB. The difference of hearing threshold between preoperative and postoperative had statistical significance (P < 0.01). ABG less than 20 dB after operationwas happened in 68.63% of the patients (74.73% for PORP and 54.17% for TORP). There was statistically significant difference between PORP and TORP (P < 0.05).
CONCLUSION
We conclude that titanium ossicular reconstruction during mastoidectomy with synchronous ossiculoplasty give stable and excellent hearing results. We obtained better results with PORP than with TORP.
Adolescent
;
Adult
;
Aged
;
Child
;
Female
;
Follow-Up Studies
;
Humans
;
Male
;
Mastoid
;
surgery
;
Middle Aged
;
Ossicular Prosthesis
;
Ossicular Replacement
;
methods
;
Retrospective Studies
;
Titanium
;
Treatment Outcome
;
Tympanoplasty
;
methods
;
Young Adult
6.The incidence of facial nerve dehiscence at mastoidectomy and its risk factors.
Guangui CHEN ; Dinghua XIE ; Huiqing XU ; Weijing WU ; Qianxu LIU
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2009;23(7):289-292
OBJECTIVE:
To study the incidence and locations of facial nerve dehiscence (FND) in mastoidectomy for the patients with cholesteatoma and chronic otitis media, and to determine its relevance as pre-operative prediction.
METHOD:
Three hundred and fifteen ears (217 ears with cholesteatoma and 98 with chronic otitis media) undergoing mastoidectomy with or without tympanoplasties were selected for retrospective study, in which the incidence and locations of FND was studied, and the relevance for FND were analyzed by univariate test following by multivariate stepwise logistic regression.
RESULT:
The presence of FND was 22.9% of total surgical procedures and the locations of FND were 93.1% in the tympanic segment, which was significantly higher than in the mastoid segment. The factors as otogenic facial paralysis, pathologic style (cholesteatoma or chronic otitis media) and lateral semicircular canal (LSC) fistula were related to FND, while others factors as sex, age, revision operations, preoperative complications, dural exposure, sigmoid sinus exposure were not risk factors for FND.
CONCLUSION
The incidence of FND was 22.9% in this study, the most common location for FND was in the tympanic segment, therefore, the facial nerves should be especially taken care in mastoidectomy for patients with presence of otogenic facial paralysis, cholesteatoma and LSC fistula.
Adolescent
;
Adult
;
Aged
;
Child
;
Cholesteatoma, Middle Ear
;
surgery
;
Chronic Disease
;
Facial Nerve Injuries
;
epidemiology
;
Female
;
Humans
;
Incidence
;
Male
;
Mastoid
;
surgery
;
Middle Aged
;
Otitis Media
;
surgery
;
Retrospective Studies
;
Young Adult